Edgewell Personal Care Co (EPC) Q2 2026 Earnings Call Transcript

Why It Matters

The divestiture sharpens Edgewell’s focus on higher‑margin core categories and improves balance‑sheet flexibility, positioning the company for sustainable growth amid inflationary pressure.

Key Takeaways

• Divestiture to Essity completed Feb 2, 2026.
• Adjusted EPS loss $0.16, includes $0.07 currency gain.
• Sun Care sales up ~8% organic, 20% overall.
• Wet Shave share down 100 bps in U.S.
• Leverage targeted to drop from 4x to 3x.

Pulse Analysis

Edgewell’s decision to spin off its feminine‑care unit mirrors a broader industry shift toward portfolio simplification, allowing companies to concentrate capital on high‑margin, growth‑oriented categories. By removing a segment that contributed roughly $44 million of adjusted EBITDA, the firm not only improves its earnings visibility but also creates a clearer margin profile for the remaining businesses. The transaction also frees up cash that management plans to deploy toward debt reduction, targeting a leverage ratio decline from around four‑times to three‑times by year‑end, thereby lowering financial risk and enhancing credit metrics.

The quarter’s operating results highlight the divergent trajectories of Edgewell’s core segments. Sun and Skin Care delivered robust organic growth—approximately 8% overall and nearly 20% in North America—driven by early‑season demand and new product launches. In contrast, Wet Shave continued to face pricing pressure and share erosion, with U.S. market share slipping 100 basis points despite a 40‑point gain for the Billy brand. International markets now represent about half of total sales, and management expects mid‑single‑digit organic growth to resume in the second quarter, underscoring the importance of geographic diversification and targeted innovation pipelines across Japan, Europe, and Oceania.

Looking ahead, Edgewell’s capital allocation strategy balances debt paydown, selective share repurchases, and disciplined brand investment. Productivity initiatives have already generated 240 basis points of gross savings, and further automation in the supply chain is projected to deepen margin expansion as inflationary pressures ease. The company’s FY2026 outlook—organic sales growth between -1% and 2%, adjusted EPS of $1.70‑$2.10, and free cash flow of $80‑$110 million—reflects confidence that the streamlined portfolio, combined with a refreshed innovation pipeline, will drive sustainable earnings momentum and deliver value to shareholders.